Conclusion of non-exclusive discount agreements according to 130a paragraph 8 SGB V with the active

Tender Notice

Tender Detail
Conclusion of non-exclusive discount agreements according to 130a paragraph 8 SGB V with the active ingredient Tafamidis 61 mg. This agreement only applies to the indication transthyretin amyloidosis with hereditary type cardiomyopathy (ATTRh-CM).
Tendering Authority
Tender Category
Other
Publish Date
23 Oct 2026
Deadline
22 Oct 2026
Country
Germany
TenderNews Ref. No.
5234416261023-0
Document Fees
Refer Document.
EMD
Refer Document.
Tender Value
Refer Document.
« Previous Tender      Next Tender »

Some of Our Valuable Clients